Amcinafal
![]()  | |
| Clinical data | |
|---|---|
| Other names | Triamcinolone pentanonide; SQ-15102; 9α-Fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with 3-pentanone; 9α-Fluoro-11β,21-dihydroxy-16α,17α-(methyl)(phenyl)methylendioxypregna-1,4-dien-3,20-dione | 
| Drug class | Corticosteroid; Glucocorticoid | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| ECHA InfoCard | 100.021.362 | 
| Chemical and physical data | |
| Formula | C26H35FO6 | 
| Molar mass | 462.558 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
Amcinafal (developmental code name SQ-15102), also known as triamcinolone pentanonide, is a synthetic glucocorticoid corticosteroid which was never marketed.[1]
References
- ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1228–. ISBN 978-1-4757-2085-3.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
